Congenital effectiveness of an inhibitor of 3 beta-hydroxysteroid dehydrogenase administered before implantation of the rat blastula.
D000273:Adipose Tissue / Q000032:analysis; D000312:Adrenal Hyperplasia, Congenital / Q000139:chemically induced*; D000731:Androstanes / Q000494:pharmacology*; D000818:Animals; D001665:Binding Sites; D010064:Embryo Implantation; D005260:Female; D005333:Fetus / Q000187:drug effects / Q000201:enzymology; D006913:Hydroxysteroid Dehydrogenases / Q000037:antagonists & inhibitors*; D007021:Hypospadias / Q000139:chemically induced; D007535:Isomerases; D007985:Leydig Cells / Q000201:enzymology; D008110:Liver Extracts / Q000032:analysis; D008297:Male; D008431:Maternal-Fetal Exchange; D009929:Organ Size; D011247:Pregnancy; D011270:Pregnancy, Animal / Q000187:drug effects*; D011549:Pseudomonas / Q000201:enzymology; D051381:Rats; D013261:Sterols / Q000494:pharmacology*; D014020:Tissue Extracts / Q000032:analysis
D000731:Androstanes; D008110:Liver Extracts; D013261:Sterols; D014020:Tissue Extracts; D006913:Hydroxysteroid Dehydrogenases; D007535:Isomerases